Dr. Kumar on the Results of the ASPIRE Trial

Results of the ASPIRE trial for MM: the addition of carfilzomibПодробнее

Dr. Kumar on Treatment Discontinuation in the ENDURANCE Myeloma TrialПодробнее

Dr. Kumar on Takeaways From the ENDURANCE Trial in Multiple MyelomaПодробнее

Dr. Kumar on Ongoing Research in Multiple MyelomaПодробнее

ENDEAVOUR, ASPIRE and TOURMALINE-MM1 trial results for multiple myelomaПодробнее

Dr. Kumar on Tourmaline-MM1 Study for Multiple MyelomaПодробнее

Dr. Kumar on the Design of a Phase II Trial Looking at MLN9708Подробнее

Venetoclax with bortezomib/dexamethasone: phase 3 BELLINI results in R/R myelomaПодробнее

Dr. Kumar on Future Treatment Landscape of Multiple MyelomaПодробнее

Updates from the BELLINI trialПодробнее

Shaji Kumar on Recent Clinical Trial Developments in MyelomaПодробнее

Case Study 1: The Value of KRd in Multiple MyelomaПодробнее

Ask the Expert: Understanding Clinical Trials by Dr Nelson MichaelПодробнее

Expert Panel: New Data in Relapsed Refractory Multiple MyelomaПодробнее

Targeting tumor protein 53 (p53): Is there anything we can do therapeutically?Подробнее

Carfilzomib Use in Multiple MyelomaПодробнее

MCP 60 Seconds With Dr Seema Kumar on Childhood ObesityПодробнее